Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Fenucure Medical ApS
APS
Active
Advertising protection
CVR 28486871
Nymøllevej 50, 2800
Kongens Lyngby
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2005 · 21 years old
1 employees
fenucure.com
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Fenucure Medical ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-1M
-1M
-2M
-2M
2021: -2M
-2M
2021
2022: -2M (0% vs 2021)
-2M
0%
2022
2023: -1M (+50% vs 2022)
-1M
+50%
2023
2024: -1M (0% vs 2023)
-1M
0%
2024
2025: -1M (0% vs 2024)
-1M
0%
2025
EBITDA
DKK millions
0M
-1M
-2M
-4M
-5M
2021: -4M
-4M
2021
2022: -3M (+25% vs 2021)
-3M
+25%
2022
2023: -3M (0% vs 2022)
-3M
0%
2023
2024: -3M (0% vs 2023)
-3M
0%
2024
2025: -3M (0% vs 2024)
-3M
0%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
-1.215
-873
-912
-1.590
-1.714
Staff expenses
-1.385
-1.735
-1.868
-1.841
-1.826
EBITDA
-2.599
-2.608
-2.780
-3.431
-3.541
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-2.599
-2.608
-2.780
-3.431
-3.541
Net financials
-120
-174
-111
-117
-115
Profit before tax
-2.719
-2.782
-2.891
-3.549
-3.655
Tax
483
-1.253
-783
-0
887
Net profit
-3.201
-1.529
-2.108
-3.549
-4.543
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
1.964
3.300
1.468
1.258
2.929
Equity
594
795
-1.676
-3.568
-2.519
Long-term debt
703
1.602
2.492
2.563
2.659
Short-term debt
667
903
651
2.263
2.789
Total debt
1.370
2.505
3.144
4.825
5.448
Financial ratios
5-year trend
EBITDA margin (of gross profit)
<−999 %
This company
2021
2025
Equity ratio
30,2 %
This company
38,2 %
Market median
This company
Market median
21% below market
2021
2025
Return on equity
-539,1 %
This company
18,4 %
Market median
This company
Market median
>999% below market
2021
2025
Net profit margin (of gross profit)
<−999 %
This company
2021
2025
Asset turnover (of gross profit)
-0,62×
This company
2021
2025
Debt / equity
2,31×
This company
0,62×
Market median
This company
Market median
273% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Fenucure Medical ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
